SENTAN Pharma Expands "Microparticulation Platform" to Broaden Reach from Pharmaceuticals to Environmental Fields

SENTAN Pharma Co., Ltd. (Fukuoka City, Fukuoka Prefecture, Representative Director Masaharu Matsubara) is developing a "Microparticulation Platform" service centered on its unique nano- and micro-particulation technology. With the expansion of this service, the company will now work to "microparticulate everything to change the social environment," extending its reach from pharmaceuticals to food, cosmetics, agriculture, feed, and pet sectors.

Overview of "Microparticulation Platform" Service

<Benefits of Microparticulation>

Microparticulation (nano- and micro-particulation) technology maximizes the inherent functions and potential of substances by reducing them to nano- and micro-sizes, thereby improving efficiency and safety. This technology is gaining attention for its ability to reduce the burden on the global environment, not just on humans and living organisms.

● Improved absorption and permeability of active ingredients

● Enhanced safety through reduced usage

● Improved Quality of Life (QOL) through sustained effects (sustained release)

● Improved resource efficiency through sustained effect manifestation (sustained release)

<Target Fields>

Our platform technology is expanding into fields that support the realization of a society coexisting with the environment, in addition to medical pharmaceuticals (nanoparticle formulations, micro sustained-release formulations).

● Food, food additives (evidence acquisition through improved absorption, effective utilization of naturally derived ingredients)

● Veterinary drugs, pet supplements (extension of healthy lifespan, improvement of breeding environment)

● Feed (improvement of farmer management and working environment through maintaining livestock health)

● Agricultural chemicals (environmental consideration through reduced usage and improved handling)

● Cosmetics, skincare (improved skin penetration)

SENTAN Pharma's Unique Technology

Our unique technology has enabled stable and mass production of nano- and micro-particles, allowing for its deployment as a practical technology in society, not just remaining at the research stage. This enables the provision of sustainable and highly reproducible solutions in fields other than pharmaceutical applications. SENTAN Pharma will contribute to the realization of a sustainable society where humans, living beings, and the global environment coexist harmoniously through its microparticulation platform.

<About SENTAN Pharma Co., Ltd.>

SENTAN Pharma, centered on its unique nano- and micro-particulation base technology, the "SENTAN Platform," is expanding its business into a wide range of fields, including pharmaceuticals, health foods like "Genmai Foodicle," and livestock/aquaculture feed like "High Gamma Oryzamil," aiming to improve the social environment through microparticulation.

https://www.sentan.co.jp/